BIA-Ceuticals is bringing a new line of cannabis based natural products with smart delivery system.
Smart Botanical Pharma
BIA-Ceuticals is bringing a new line of cannabis based botanical drugs and products with smart delivery system.
Our products combine cannabis with traditional medicinal plants, working synergistically, to form a potent formulation.
Innovative
Formulation
Our Products will contain a unique combination of 3 main ingredients:
Cannabis extract of special CBD reach propriety strains and two other natural plant ingredients with proven antiseptic and anti-inflammatory properties.
Patented
Technology
3 levels of patent protection (Formula, delivery system, pre- clinical model) will ensure a strong and secure product patent.
Enhanced Drug
Delivery System
Our products will incorporate a novel patented delivery system, which would enhance absorption and local bioavailability of CBD and other ingredients.
About Us
BIA is an Israeli startup group developing innovative natural products based on medical cannabis and herbal ingredients with proven efficacy.
BIA has obtained specialized license from the Israeli Ministry of Health, to develop a line of innovative natural products based on medical cannabis.
Our mission is to produce natural alternatives for standard treatments of common symptoms, with similar or superior efficacy to current treatments.
Research & Development
Development of BIA products will be conducted at Ben-Gurion University as well as the Hebrew University of Jerusalem, Givat Ram, taking advantage of the facilities, services and expertise offered by the universities.
1st stage of development, will take 18 months, at the end of which 4 products will be ready for market.
The 2nd stage, will take a further 18 months, and yield 6 more products ready for market.
Clinical Trials
BIA business model puts an emphasis on testing its products in clinical trials to prove efficacy and promote trust in the brand and its products.
Our products will be tested first in tissue culture for activity and then in human clinical trials for safety and efficacy.
Our Team
Guy Landver
Chairman & CTO
Guy Landver is a pharmaceutical engineer, and the inventor of BIA's product line. Researcher of traditional medicine for over 25 years, and recently completed his latest research, at the Hebrew University, school of Pharmacy, into the molecular mechanism by which Cannabis and specifically Cannabidiol exhorts its therapeutic effects upon the central nervous system via Transient receptor potential Ankyrin 1, a newly identified receptor involved in the pain and inflammation pathway. Guy is responsible for primary product formulation, conducting the laboratory development phase, and overseeing the entire project.
Dr. Eitan Moore
VP R&D
Dr. Eitan Moore is a former head of R&D and VP Technologies at Intec Pharma-a drug delivery company. He has obtained his Ph.D. in Neuropharmacology from the University of Groningen in the Netherlands, did his post-doc at the School of Pharmacy of the Hebrew University and worked in Pharmaceutical companies in Israel and Europe and has many patents and scientific publications to his name. Eitan is responsible for the development of formulations, and production methods at BIA Ceuticals.
Tom Gross
VP Business Development
Tom Gross brings more than twenty years of experience in sales, marketing, operations and branding. Tom trained and led sales teams, managed and assisted the foundation of sales related companies in the fields of pharmaceuticals, tourism, and journalism. Over the last few years, he has been a sales and marketing strategy consultant to private companies, in Israel and abroad. Tom is responsible for business development, strategic financial planning, product marketing and sales. Tom studied piano performance at the Buchman-Mehta school of music in Tel aviv university, and has been teaching music theory and the art of piano playing over the past 20 years.